Nutromics Raises \$35 Million for Breakthrough Wearable Diagnostic Patch
Nutromics, an Australian medical technology company, has raised \$35 million to develop a wearable diagnostic patch using synthetic DNA-based sensors; this technology enables continuous, real-time monitoring of multiple clinically relevant targets for some of the deadliest diseases, with clinical tr...
Nutromics Raises \$35 Million for Breakthrough Wearable Diagnostic Patch
Nutromics, an Australian medical technology company, has raised \$35 million to develop a wearable diagnostic patch using synthetic DNA-based sensors; this technology enables continuous, real-time monitoring of multiple clinically relevant targets for some of the deadliest diseases, with clinical tr...
Progress
48% Bias Score
OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
Progress
48% Bias Score
"Moroccan Firm Moldiag Addresses African Monkeypox Diagnostic Gap with Affordable Tests"
"Moldiag, a Moroccan company, is producing and distributing affordable monkeypox tests (\$5) across Africa, addressing critical diagnostic gaps and aiming to improve response times to outbreaks, though it awaits WHO approval."
"Moroccan Firm Moldiag Addresses African Monkeypox Diagnostic Gap with Affordable Tests"
"Moldiag, a Moroccan company, is producing and distributing affordable monkeypox tests (\$5) across Africa, addressing critical diagnostic gaps and aiming to improve response times to outbreaks, though it awaits WHO approval."
Progress
36% Bias Score
Moroccan Firm Fills African Mpox Test Shortage
Moldiag, a Moroccan startup, is filling mpox test orders in several African countries, addressing shortages and fulfilling a key objective of the African Union after the COVID-19 pandemic highlighted unequal access to medical supplies.
Moroccan Firm Fills African Mpox Test Shortage
Moldiag, a Moroccan startup, is filling mpox test orders in several African countries, addressing shortages and fulfilling a key objective of the African Union after the COVID-19 pandemic highlighted unequal access to medical supplies.
Progress
44% Bias Score
Moroccan Startup Moldiag Fills Critical Mpox Test Shortage in Africa
A Moroccan company, Moldiag, is the first in Africa to produce mpox tests, filling a critical need as the continent battles an outbreak with over 59,000 cases and 1,164 deaths. The $5 tests are already being distributed to several African nations.
Moroccan Startup Moldiag Fills Critical Mpox Test Shortage in Africa
A Moroccan company, Moldiag, is the first in Africa to produce mpox tests, filling a critical need as the continent battles an outbreak with over 59,000 cases and 1,164 deaths. The $5 tests are already being distributed to several African nations.
Progress
44% Bias Score
NSU Develops AI for Precise Brain Tumor Diagnosis
Novosibirsk State University scientists created a software module using MRI images to diagnose brain tumors with high accuracy, based on a database of over 1000 patients from the Federal Neurosurgery Center, improving treatment planning and patient outcomes.
NSU Develops AI for Precise Brain Tumor Diagnosis
Novosibirsk State University scientists created a software module using MRI images to diagnose brain tumors with high accuracy, based on a database of over 1000 patients from the Federal Neurosurgery Center, improving treatment planning and patient outcomes.
Progress
48% Bias Score
Proteomics International Secures \$2.16 Million R&D Rebate for Diagnostic Blood Tests
Proteomics International secured a \$2.16 million Australian R&D tax rebate to commercialize its innovative blood tests for diabetic kidney disease, endometriosis, and esophageal cancer, leveraging a \$4.95 million R&D investment and aiming for US market entry.
Proteomics International Secures \$2.16 Million R&D Rebate for Diagnostic Blood Tests
Proteomics International secured a \$2.16 million Australian R&D tax rebate to commercialize its innovative blood tests for diabetic kidney disease, endometriosis, and esophageal cancer, leveraging a \$4.95 million R&D investment and aiming for US market entry.
Progress
40% Bias Score
€4.7M EU Center to Develop Infectious Disease Diagnostics
A new €4.7 million EU-funded center, DxHub, will be created at the Foundation for Research and Technology - Hellas (FORTH) in January 2025 to develop innovative diagnostic tools for infectious diseases, specifically addressing the increasing threat in Southern Europe and the Mediterranean, and colla...
€4.7M EU Center to Develop Infectious Disease Diagnostics
A new €4.7 million EU-funded center, DxHub, will be created at the Foundation for Research and Technology - Hellas (FORTH) in January 2025 to develop innovative diagnostic tools for infectious diseases, specifically addressing the increasing threat in Southern Europe and the Mediterranean, and colla...
Progress
4% Bias Score
African Startup Moldiag Fills Mpox Testing Gap
Moldiag, a Moroccan startup, is the first African company to mass-produce and distribute mpox tests, addressing shortages and high costs in an outbreak affecting over 59,000 people across 20 African countries, fulfilling a post-COVID-19 commitment by African nations to reduce medical import dependen...
African Startup Moldiag Fills Mpox Testing Gap
Moldiag, a Moroccan startup, is the first African company to mass-produce and distribute mpox tests, addressing shortages and high costs in an outbreak affecting over 59,000 people across 20 African countries, fulfilling a post-COVID-19 commitment by African nations to reduce medical import dependen...
Progress
40% Bias Score